Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Third-party tested, with a Certificate of Analysis (CoA) available on request to support method development, analytical characterisation, and laboratory reference applications
The full Thymosin Beta-4 molecule, under the name RGN-259, has entered formal clinical trials for conditions including dry eye disease and cardiac recovery, which validates the underlying biological mechanism that TB-500 shares
Covered code lists are MAC-specific, so verify with your Medicare Administrative Contractors Local Coverage Determination
Results can vary, but many owners report improvements in energy, recovery, and coat condition within 24 weeks
Timeframe Weeks 6-12 Commonly tracked Extended-cycle community reports Notes No human RCT covers this duration
US$ 22.27
US$ 28.22
US$ 27.80
%20(1).png)
